Amarin Corp Plc (AMRN)

[sharinky]

We could wake up any morning to submission in Europe. Recent language from Amarin changed from before the end fo the year to fourth quarter submission.

HLS is expecting approval in Canada before the end of the year with launch in 1st Qtr 2020. If FDA actually waits until PDUFA date, Canada will actually approve a drug before the FDA. That will be quite a sight to see and I expect there will be much publicity regarding that. After the stellar Reduce-it results, HLS expects to gladly pay out all of their milestones to Amarin. We should also be seeing more information coming out of Cadth before the end of the year on their drug review.

This is going to come down to sales. As sales continue to escalate there will still be those that say but what about the M.O and the intellectual property. Amarin will crush any remaining doubts in the next four months.